Antenatal management of HNF4A-MODY and INSR mutations in pregnancy

妊娠期HNF4A-MODY和INSR突变的产前管理

阅读:2

Abstract

We report the case of a pregnant woman with coexisting pathogenic hepatocyte nuclear factor 4 alpha (HNF4A) and insulin receptor (INSR) gene variants. A 25-year-old lean Caucasian gravida 1, para 0 (G1P0) woman with a history of early-onset diabetes and features of insulin resistance, was referred at 6 weeks' gestation. Molecular testing confirmed pathogenic variants in HNF4A and INSR. Noninvasive prenatal testing predicted fetal inheritance of the HNF4A variant. Despite good maternal glycemic control and relatively low insulin requirements, the infant was macrosomic and developed persistent postnatal hypoglycemia requiring prolonged diazoxide therapy. This case highlights the importance of early recognition of monogenic diabetes in pregnancy, the potential utility of noninvasive prenatal testing, and the observation of persistent hyperinsulinemia beyond the neonatal period in HNF4A-related diabetes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。